Byline: Elaine Goodman
Publication: WorkCompCentral
Date: Friday, November 16, 2018
Intrathecal pumps, drug-delivery systems that have been controversial in workers’ compensation, are the subject of a warning issued Thursday by the U.S. Food and Drug Administration.
The FDA has cautioned against using the pumps to deliver drugs that aren’t approved…
Login required to read the full article here: Unapproved Drugs Add to Intrathecal Pump Risk
Share
Share
Tweet
Email